Meloxicam and Voltaren (diclofenac) both reduce pain and inflammation, but differ in potency and mechanism. Meloxicam, a COX-2 inhibitor, generally shows stronger anti-inflammatory action compared to diclofenac, a non-selective NSAID that inhibits both COX-1 and COX-2. This means Meloxicam may be more effective for managing inflammation in conditions like osteoarthritis.
Pain Relief: Meloxicam vs. Diclofenac
Studies show comparable analgesic effects for both drugs in treating mild to moderate pain associated with osteoarthritis and rheumatoid arthritis. Patient response varies, however, meaning one drug might work better for a specific individual. Consider starting with a lower dose and carefully monitoring pain relief and side effects.
Anti-inflammatory Properties: A Closer Look
Meloxicam’s selectivity for COX-2 contributes to a reduced risk of gastrointestinal side effects compared to diclofenac. Diclofenac, due to its non-selective action, carries a higher risk of stomach upset, ulcers, and bleeding. This difference is a significant factor in choosing between the two drugs, particularly for individuals with a history of gastrointestinal issues.
Always consult your doctor or pharmacist to determine which medication is most appropriate for your specific needs and health condition. Individual responses to medication vary significantly.
